Skip to main content
Log in

Metabolic effects of isradipine in non-insulin-dependent diabetes mellitus (NIDDM) hypertensive patients

  • Letter To The Editor
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Mancini M, Ferrara LA, Strazzullo P, Marotta T. Metabolic disturbances and antihypertensive therapy.J. Hypertens 1991;9(Suppl 3):S47-S50.

    Google Scholar 

  2. Pedersen OL, Krusell LR, Inger S, Jespersen LT, Thomsen K. Long-term effects of isradipine on blood pressure and renal function.Am J Med 1989;86(Suppl 4A):15–18.

    Google Scholar 

  3. Wilson PWF, Castelli WP, Kannel WB. Coronary risk prediction in adults (the Framingham Heart Study).Am J Cardiol 1987;59;91G-94G.

    Google Scholar 

  4. Charles S, Ketelslegers JM, Buysschaert M, Lambert AE. Hyperglycaemic effect of nifedipine.Br Med J 1981;289:19–20.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ferrara, L.A., De Simone, G., Iannuzzi, R. et al. Metabolic effects of isradipine in non-insulin-dependent diabetes mellitus (NIDDM) hypertensive patients. Cardiovasc Drug Ther 9, 459–460 (1995). https://doi.org/10.1007/BF00879035

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00879035

Keywords

Navigation